Evidence map›Paper›PMID 26630267›Full record

ArticlePloS one2015

Oocyte Scoring Enhances Embryo-Scoring in Predicting Pregnancy Chances with IVF Where It Counts Most.

Emanuela Lazzaroni-Tealdi, David H Barad, David F Albertini, Yao Yu, Vitaly A Kushnir, Helena Russell, Yan-Guang Wu, Norbert Gleicher

4 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02974517 unknown statusnot on this mapstarted 2016, after this paper: background citation

The Application of Time-lapse System in IVF/ICSI: Can it be Beneficial to Final Pregnancy Outcome?

TypeobservationalSponsorThe First Affiliated Hospital of Zhengzhou UniversityRan2016Enrolled300Conditionsthe Application of Time-lapes System in IVF/ICSIArmsEmbryoScope®
NCT04724486 phase4completednot on this mapstarted 2020, after this paper: background citation

Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on Oocyte Morphology During IVF/ICSI

TypeinterventionalSponsorDamascus UniversityRan2020 to 2022Enrolled50ConditionsIn Vitro Fertilization, Intracytoplasmic Sperm Injection, InfertilityArmsTriptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin, Human Chorionic Gonadotropin (hCG)
NCT04727684 phase4completednot on this mapstarted 2020, after this paper: background citation

Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

TypeinterventionalSponsorDamascus UniversityRan2020 to 2022Enrolled50ConditionsIn Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection, Polycystic Ovary SyndromeArmsTriptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin, Human Chorionic Gonadotropin (hCG)
NCT06019494 nacompletednot on this mapstarted 2023, after this paper: background citation

Is Flow Rate During Oocyte Retrieval Associated With the Number of Oocytes Retrieved? A Randomized Control Trial

TypeinterventionalSponsorEugoniaRan2023 to 2024Enrolled42ConditionsInfertilityArmsOocyte retrieval with low aspiration flow rate, Oocyte retrieval with high aspiration flow rate
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Emanuela Lazzaroni-TealdiThe Center for Human Reproduction, New York, New York, United States of America.
David H BaradThe Center for Human Reproduction, New York, New York, United States of America.
David F AlbertiniThe Center for Human Reproduction, New York, New York, United States of America.
Yao YuThe Center for Human Reproduction, New York, New York, United States of America.
Vitaly A KushnirThe Center for Human Reproduction, New York, New York, United States of America.
Helena RussellSchool of Health Professions, Eastern Virginia Medical School, Norfolk, Virginia, United States of America.
Yan-Guang WuThe Center for Human Reproduction, New York, New York, United States of America.
Norbert GleicherThe Center for Human Reproduction, New York, New York, United States of America.
Center for Human Reproduction · USAlbert Einstein College of Medicine · USEastern Virginia Medical School · USFoundation for Reproductive Medicine · USWake Forest University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextOur center's quality improvement optimization process on many occasions anecdotally suggested that oocyte assessments might enhance embryo assessment in predicting pregnancy chances with in vitro fertilization (IVF).

objectiveTo prospectively compare a morphologic oocyte grading system to standard day-3 morphologic embryo assessment. DESIGN, SETTING, PATIENTS: We prospectively investigated in a private academically-affiliated infertility center 94 consecutive IVF cycles based on 6 criteria for oocyte quality: morphology, cytoplasm, perivitelline space (PVS), zona pellucida (ZP), polar body (PB) and oocyte size, each assigned a value of -1 (worst), 0 (average) or +1 (best), so establishing an average total oocyte score (TOS). Embryo assessment utilized grade and cell numbers of each embryo on day-3 after oocyte retrieval. Clinical pregnancy was defined by presence of at least one intrauterine gestational sac.

interventionsStandard IVF cycles in infertile women.

main outcome measuresPredictability of pregnancy based on oocyte and embryo-grading systems.

resultsAverage age for all patients was 36.5 ± 7.3 years; mean oocyte yield was 7.97± 5.76; Patient specific total oocyte score (PTOS) was -1.05 ± 2.24. PTOS, adjusted for patient age, was directly related to odds of increased embryo cell numbers (OR 1.12, P = 0.025), embryo grade (OR 1.19, P < 0.001) and clinical pregnancy [OR 1.58 (95%CI 1.23 to 2.02), P < 0.001]. Restricting the analysis to day three embryos of high quality (8-cell/ good grades), TOS was still predictive of clinical pregnancy (OR 2.08 (95%CI 1.26 to 3.44, P = 0.004). Among the 69 patients with embryos of Grade 4 or better available for transfer 23 achieved Clinical Pregnancy. When the analysis was restricted to the 69 transfers with good quality embryos (≥ Grade 4) the Oocyte Scoring System (TOS) (AUC±SE 0.863±0.044, oocyte score) provided significantly greater predictive value for clinical pregnancy compared to the embryo grade alone (AUC 0.646 ± 0.072, embryo grade) p = 0.015.

conclusionsOocyte-scoring, thus, provides useful clinical information especially in good prognosis patients with large numbers of high quality embryos. This finding appears of particular importance at a time when many IVF centers are committing sizable investments to closed incubation systems with time-lapse photography, which are exclusively meant to define embryo morphology.

Indexed as

AdultEmbryo, MammalianFemaleFertilization in VitroHumansOocytesPregnancyTreatment Outcome

Identifiers

PMID26630267
PMCPMC4668065
OpenAlexW2271623863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.